TransMabs: cell-penetrating antibodies, the next generation (Q36065969)

12 August 2017

1 reference

title

TransMabs: cell-penetrating antibodies, the next generation (English)

1 reference

12 August 2017

Sybille Muller

1

1 reference

12 August 2017

Yunfeng Zhao

2

1 reference

12 August 2017

Thomas L Brown

3

1 reference

12 August 2017

Alton C Morgan

4

1 reference

12 August 2017

Heinz Kohler

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Expert Opinion on Biological Therapy

12 August 2017

1 reference

12 August 2017

5

1 reference

12 August 2017

2

1 reference

12 August 2017

237-241

1 reference

Superantibody activities: new players in innate and adaptive immune responses.

12 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

Enhancing tumor targeting and apoptosis using noncovalent antibody homodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

Genetic engineering of proteins with cell membrane permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

Chemical engineering of cell penetrating antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

MTS-conjugated-antiactive caspase 3 antibodies inhibit actinomycin D-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

Apoptosis in B lymphocytes: the WEHI-231 perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

A cleavage-site-directed inhibitor of interleukin-1 beta-converting enzyme-like proteases inhibits apoptosis in primary cultures of rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

Mechanisms of TGF-beta-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

Transforming growth factor beta induces caspase 3-independent cleavage of alphaII-spectrin (alpha-fodrin) coincident with apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

Non-specific effects of methyl ketone peptide inhibitors of caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

Update on HER-2 as a target for cancer therapy: herceptin in the clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.2.237

21 January 2018

Identifiers

DOI

10.1517/14712598.5.2.237

1 reference

12 August 2017

1 reference